SV40 T antigen transgenic mice: cytotoxic T lymphocytes as a selective force in tumor progression.
Knowles
B B
BB
Wistar Institute, Philadelphia, PA 19104.
Faas
S
S
Juretic
A
A
Fox
N
N
Crooke
R
R
Hanahan
D
D
Solter
D
D
Jewett
L
L
D000681:Amylases / Q000633:toxicity; D000818:Animals; D000952:Antigens, Polyomavirus Transforming / Q000235:genetics* / Q000276:immunology; D002273:Carcinogens / Q000633:toxicity; D016545:Choroid Plexus Neoplasms / Q000209:etiology / Q000235:genetics / Q000276:immunology / Q000473:pathology; D006183:H-2 Antigens / Q000096:biosynthesis / Q000276:immunology; D006965:Hyperplasia; D007114:Immunization; D007328:Insulin / Q000633:toxicity; D008067:Lipoma / Q000209:etiology / Q000235:genetics / Q000276:immunology / Q000473:pathology; D051379:Mice; D008822:Mice, Transgenic; D009374:Neoplasms, Experimental / Q000209:etiology / Q000235:genetics / Q000276:immunology* / Q000473:pathology; D010190:Pancreatic Neoplasms / Q000209:etiology / Q000235:genetics / Q000276:immunology / Q000473:pathology; D051381:Rats; D011994:Recombinant Proteins / Q000235:genetics* / Q000276:immunology; D013539:Simian virus 40 / Q000276:immunology*; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology*; D014407:Tumor Cells, Cultured / Q000276:immunology / Q000473:pathology; D014412:Tumor Virus Infections / Q000276:immunology*
D000952:Antigens, Polyomavirus Transforming; D002273:Carcinogens; D006183:H-2 Antigens; D007328:Insulin; D011994:Recombinant Proteins; D000681:Amylases